A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study.
about
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A Multicenter Clinical Phase I ...... orectal Cancer: QUATTRO Study.
@en
A Multicenter Clinical Phase I ...... orectal Cancer: QUATTRO Study.
@nl
type
label
A Multicenter Clinical Phase I ...... orectal Cancer: QUATTRO Study.
@en
A Multicenter Clinical Phase I ...... orectal Cancer: QUATTRO Study.
@nl
prefLabel
A Multicenter Clinical Phase I ...... orectal Cancer: QUATTRO Study.
@en
A Multicenter Clinical Phase I ...... orectal Cancer: QUATTRO Study.
@nl
P2093
P50
P1476
A Multicenter Clinical Phase I ...... lorectal Cancer: QUATTRO Study
@en
P2093
Akihito Tsuji
Akiyoshi Kanazawa
Goro Nakayama
Hideki Sakisaka
Hiroya Taniguchi
Kentaro Yamazaki
Masahito Kotaka
Masato Nakamura
Shigeyoshi Iwamoto
P304
P356
10.1016/J.CLCC.2018.01.011
P407
P577
2018-02-09T00:00:00Z